On the public citation graph
Alpha-synuclein: from secretion to dysfunction and death
0 signed · 365 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ana.21685openalex-snapshot
SNCA variants are associated with increased risk for multiple system atrophy
inferredcites →https://doi.org/10.1006/bbrc.1999.0651openalex-snapshot
Interaction Cloning and Characterization of the cDNA Encoding the Human Prenylated Rab Acceptor (PRA1)
inferredcites →https://doi.org/10.1007/s00401-010-0711-0openalex-snapshot
The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
inferredcites →https://doi.org/10.1007/s00702-005-0427-9openalex-snapshot
The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy
inferredcites →https://doi.org/10.1007/s12031-010-9455-5openalex-snapshot
Aggregation of α-Synuclein in S. cerevisiae is Associated with Defects in Endosomal Trafficking and Phospholipid Biosynthesis
inferredcites →https://doi.org/10.1007/s12640-009-9053-xopenalex-snapshot
Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity
inferredcites →https://doi.org/10.1016/0014-5793(94)00395-5openalex-snapshot
Identification of two distinct synucleins from human brain
inferredcites →https://doi.org/10.1016/0304-3940(94)90746-3openalex-snapshot
Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
inferredcites →https://doi.org/10.1016/0304-3940(95)12192-7openalex-snapshot
Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
inferredcites →https://doi.org/10.1016/0896-6273(95)90302-xopenalex-snapshot
The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
inferredcites →https://doi.org/10.1016/j.bbr.2009.06.008openalex-snapshot
In vivo imaging of synaptic function in the central nervous system
inferredcites →https://doi.org/10.1016/j.bbrc.2006.08.024openalex-snapshot
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease
inferredcites →https://doi.org/10.1016/j.bbrc.2007.04.108openalex-snapshot
Expression of α-synuclein, a presynaptic protein implicated in Parkinson’s disease, in erythropoietic lineage
inferredcites →https://doi.org/10.1016/j.bbrc.2011.07.028openalex-snapshot
Human α-synuclein modulates vesicle trafficking through its interaction with prenylated Rab acceptor protein 1
inferredcites →https://doi.org/10.1016/j.biocel.2008.01.017openalex-snapshot
Assembly-dependent endocytosis and clearance of extracellular a-synuclein
inferredcites →https://doi.org/10.1016/j.cell.2005.09.028openalex-snapshot
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
inferredcites →https://doi.org/10.1016/j.gde.2009.03.008openalex-snapshot
The genetics of Parkinson's syndromes: a critical review
inferredcites →https://doi.org/10.1016/j.nbd.2005.03.010openalex-snapshot
Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein
inferredcites →https://doi.org/10.1016/j.nbd.2007.06.016openalex-snapshot
Role of α-synuclein in synaptic glutamate release
inferredcites →https://doi.org/10.1016/j.nbd.2011.01.029openalex-snapshot
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
inferredcites →https://doi.org/10.1016/j.neures.2010.12.020openalex-snapshot
Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line
inferredcites →https://doi.org/10.1016/j.neuron.2005.05.010openalex-snapshot
Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease
inferredcites →https://doi.org/10.1016/j.neuron.2009.12.023openalex-snapshot
Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
inferredcites →https://doi.org/10.1016/j.parkreldis.2004.10.013openalex-snapshot
Neuroinflammatory processes in Parkinson's disease
inferredcites →https://doi.org/10.1016/s0140-6736(10)62345-8openalex-snapshot
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
inferredcites →https://doi.org/10.1016/s0197-4580(02)00065-9openalex-snapshot
Staging of brain pathology related to sporadic Parkinson’s disease
inferredcites →https://doi.org/10.1016/s0304-3940(98)00504-7openalex-snapshot
Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
inferredcites →https://doi.org/10.1016/s0896-6273(00)80886-7openalex-snapshot
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
inferredcites →https://doi.org/10.1016/s0896-6273(01)00462-7openalex-snapshot
β-Synuclein Inhibits α-Synuclein Aggregation
inferredcites →https://doi.org/10.1021/bi050352oopenalex-snapshot
Kinetic Stabilization of an Oligomeric Protein under Physiological Conditions Demonstrated by a Lack of Subunit Exchange: Implications for Transthyretin Amyloidosis
inferredcites →https://doi.org/10.1021/ja044351fopenalex-snapshot
Potent and Selective Structure-Based Dibenzofuran Inhibitors of Transthyretin Amyloidogenesis: Kinetic Stabilization of the Native State
inferredcites →https://doi.org/10.1038/emboj.2009.257openalex-snapshot
Pre‐fibrillar α‐synuclein variants with impaired β‐structure increase neurotoxicity in Parkinson's disease models
inferredcites →https://doi.org/10.1038/embor.2010.66openalex-snapshot
α‐Synuclein sequesters arachidonic acid to modulate SNARE‐mediated exocytosis
inferredcites →https://doi.org/10.1038/nature02057openalex-snapshot
Yip3 catalyses the dissociation of endosomal Rab–GDI complexes
inferredcites →https://doi.org/10.1038/nature10324openalex-snapshot
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
inferredcites →https://doi.org/10.1038/nm1746openalex-snapshot
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
inferredcites →https://doi.org/10.1038/nm1747openalex-snapshot
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
inferredcites →https://doi.org/10.1038/sj.emboj.7600451openalex-snapshot
α‐Synuclein produces a long‐lasting increase in neurotransmitter release
inferredcites →https://doi.org/10.1073/pnas.0710685105openalex-snapshot
The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis
inferredcites →https://doi.org/10.1073/pnas.0903691106openalex-snapshot
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
inferredcites →https://doi.org/10.1073/pnas.0908005106openalex-snapshot
Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells
inferredcites →https://doi.org/10.1073/pnas.1005005107openalex-snapshot
αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction
inferredcites →https://doi.org/10.1073/pnas.1100976108openalex-snapshot
In vivo demonstration that α-synuclein oligomers are toxic
inferredcites →https://doi.org/10.1073/pnas.90.23.11282openalex-snapshot
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
inferredcites →https://doi.org/10.1073/pnas.95.11.6469openalex-snapshot
α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies
inferredcites →https://doi.org/10.1073/pnas.97.2.571openalex-snapshot
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
inferredcites →https://doi.org/10.1074/jbc.273.16.9443openalex-snapshot
Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes
inferredcites →https://doi.org/10.1074/jbc.m004345200openalex-snapshot
α-Synuclein Membrane Interactions and Lipid Specificity
inferredcites →https://doi.org/10.1074/jbc.m008919200openalex-snapshot
A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly
inferredcites →https://doi.org/10.1074/jbc.m009073200openalex-snapshot
PRA Isoforms Are Targeted to Distinct Membrane Compartments
inferredcites →https://doi.org/10.1074/jbc.m109.081125openalex-snapshot
Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies
inferredcites →https://doi.org/10.1074/jbc.m503341200openalex-snapshot
Proteolytic Cleavage of Extracellular Secreted α-Synuclein via Matrix Metalloproteinases
inferredcites →https://doi.org/10.1074/jbc.m909309199openalex-snapshot
PRA1 Inhibits the Extraction of Membrane-bound Rab GTPase by GDI1
inferredcites →https://doi.org/10.1091/mbc.e09-09-0801openalex-snapshot
α-Synuclein Delays Endoplasmic Reticulum (ER)-to-Golgi Transport in Mammalian Cells by Antagonizing ER/Golgi SNAREs
inferredcites →https://doi.org/10.1093/brain/awq132openalex-snapshot
SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson’s disease
inferredcites →https://doi.org/10.1096/fj.03-0098fjeopenalex-snapshot
α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma
inferredcites →https://doi.org/10.1096/fj.04-2751comopenalex-snapshot
Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease
inferredcites →https://doi.org/10.1096/fj.10-164624openalex-snapshot
Heat‐shock protein 70 modulates toxic extracellular α‐synuclein oligomers and rescues trans‐synaptic toxicity
inferredcites →https://doi.org/10.1111/j.1471-4159.2009.06324.xopenalex-snapshot
Seeding induced by α‐synuclein oligomers provides evidence for spreading of α‐synuclein pathology
inferredcites →https://doi.org/10.1111/j.1471-4159.2010.06695.xopenalex-snapshot
Non‐classical exocytosis of α‐synuclein is sensitive to folding states and promoted under stress conditions
inferredcites →https://doi.org/10.1111/j.1471-4159.2011.07576.xopenalex-snapshot
α‐Synuclein oligomers oppose long‐term potentiation and impair memory through a calcineurin‐dependent mechanism: relevance to human synucleopathic diseases
inferredcites →https://doi.org/10.1126/science.1090439openalex-snapshot
Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology
inferredcites →https://doi.org/10.1126/science.1129462openalex-snapshot
α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models
inferredcites →https://doi.org/10.1126/science.1195227openalex-snapshot
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
inferredcites →https://doi.org/10.1159/000097237openalex-snapshot
Evaluation of Interleukins, ACTH, Cortisol and Prolactin Concentrations in the Blood of Patients with Parkinson's Disease
inferredcites →https://doi.org/10.1159/000112832openalex-snapshot
Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood
inferredcites →https://doi.org/10.1172/jci43366openalex-snapshot
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
inferredcites →https://doi.org/10.1186/1742-2094-2-14openalex-snapshot
Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
inferredcites →https://doi.org/10.1186/1742-2094-8-166openalex-snapshot
The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
inferredcites →https://doi.org/10.1212/wnl.38.8.1285openalex-snapshot
Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
inferredcites →https://doi.org/10.1371/journal.pone.0013481openalex-snapshot
Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants
inferredcites →https://doi.org/10.1371/journal.pone.0029460openalex-snapshot
The AAA-ATPase VPS4 Regulates Extracellular Secretion and Lysosomal Targeting of α-Synuclein
inferredcites →https://doi.org/10.1523/jneurosci.0285-07.2007openalex-snapshot
Aggregated α-Synuclein Mediates Dopaminergic Neurotoxicity In Vivo
inferredcites →https://doi.org/10.1523/jneurosci.0692-05.2005openalex-snapshot
Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates
inferredcites →https://doi.org/10.1523/jneurosci.08-08-02804.1988openalex-snapshot
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
inferredcites →https://doi.org/10.1523/jneurosci.1091-10.2010openalex-snapshot
A Pathologic Cascade Leading to Synaptic Dysfunction in -Synuclein-Induced Neurodegeneration
inferredcites →https://doi.org/10.1523/jneurosci.1594-04.2004openalex-snapshot
Lipid Rafts Mediate the Synaptic Localization of α-Synuclein
inferredcites →https://doi.org/10.1523/jneurosci.20-09-03214.2000openalex-snapshot
Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons.
inferredcites →https://doi.org/10.1523/jneurosci.2559-04.2004openalex-snapshot
Role of α-Synuclein in Presynaptic Dopamine Recruitment
inferredcites →https://doi.org/10.1523/jneurosci.2617-07.2007openalex-snapshot
Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding
inferredcites →https://doi.org/10.1523/jneurosci.2922-05.2005openalex-snapshot
Neural Activity Controls the Synaptic Accumulation of α-Synuclein
inferredcites →https://doi.org/10.1523/jneurosci.5699-09.2010openalex-snapshot
Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival
inferredcites →https://doi.org/10.2144/000112691openalex-snapshot
Selective Detection, Quantification, and Subcellular Location of α-Synuclein Aggregates with a Protein Aggregate Filtration Assay
inferredcites →https://doi.org/10.3389/fnins.2011.00080openalex-snapshot
α-Synuclein Alters Toll-Like Receptor Expression
inferredcites →https://doi.org/10.3858/emm.2011.43.4.026openalex-snapshot
Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.5046978openalex-extracted
Lead as an Environmental Toxicant in Models of Synucleinopathies
inferred← citeshttps://doi.org/10.1002/ana.24066openalex-snapshot
Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys
inferred← citeshttps://doi.org/10.1002/glia.23645openalex-snapshot
GlialHMOX1expression promotes central and peripheral α‐synuclein dysregulation and pathogenicity in parkinsonian mice
inferred← citeshttps://doi.org/10.1002/iid3.39openalex-snapshot
Chaperoned amyloid proteins for immune manipulation: α‐Synuclein/Hsp70 shifts immunity toward a modulatory phenotype
inferred← citeshttps://doi.org/10.1002/jcp.27404openalex-snapshot
Curcumin: A naturally occurring autophagy modulator
inferred← citeshttps://doi.org/10.1002/jnr.25171openalex-snapshot
SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives
inferred← citeshttps://doi.org/10.1002/mds.27935openalex-snapshot
Salivary microR‐153 and microR‐223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease
inferred← citeshttps://doi.org/10.1002/mds.29736openalex-snapshot
Functional Study of SNCA p. V15A Variant: Further Linking α‐Synuclein and Glucocerebrosidase
inferred← citeshttps://doi.org/10.1002/pep2.24095openalex-snapshot
Amyloid self‐assembling peptides: Potential applications in nanovaccine engineering and biosensing
inferred← citeshttps://doi.org/10.1002/pmic.201800161openalex-snapshot
Proteomic and Post‐Translational Modification Profiling of Exosome‐Mimetic Nanovesicles Compared to Exosomes
inferred← citeshttps://doi.org/10.1007/978-1-0716-3662-6_32openalex-snapshot
Chrysin for Neurotrophic and Neurotransmitter Balance in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4614-5836-4_110openalex-snapshot
Neurodegenerative Aspects of Multiple System Atrophy
inferred← citeshttps://doi.org/10.1007/978-3-031-15080-7_110openalex-snapshot
Neurodegenerative Aspects of Multiple System Atrophy
inferred← citeshttps://doi.org/10.1007/978-3-319-08046-8_1openalex-snapshot
Parkinson’s Disease: An Overview of Etiology, Clinical Manifestations, and Treatment
inferred← citeshttps://doi.org/10.1007/978-3-319-08046-8_2openalex-snapshot
Neuropathology of Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-40560-5_1646openalex-snapshot
Lewy Bodies, Achalasia
inferred← citeshttps://doi.org/10.1007/978-981-13-3585-3_2openalex-snapshot
Molecular Marker and Therapeutic Regimen for Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-981-97-0308-1_15openalex-snapshot
Polyphenols and its Nano Formulations as Therapeutic Agents Against Parkinson's and Alzheimer's Dementia
inferred← citeshttps://doi.org/10.1007/s00018-026-06126-zopenalex-snapshot
Alpha-synuclein overexpression triggers divergent cellular responses and post-translational modifications in SH-SY5Y and ReNcell VM models
inferred← citeshttps://doi.org/10.1007/s00204-017-2133-4openalex-snapshot
An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition
inferred← citeshttps://doi.org/10.1007/s00204-025-03994-5openalex-snapshot
Potential role of ochratoxin A in Parkinson’s disease: a systematic review of current evidence
inferred← citeshttps://doi.org/10.1007/s00401-014-1314-yopenalex-snapshot
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s00415-022-11267-9openalex-snapshot
Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s00702-013-1149-zopenalex-snapshot
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s11055-019-00769-1openalex-snapshot
An Infection Hypothesis of Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s11055-021-01120-3openalex-snapshot
Assessment of the Efficacy of Preventive Therapy with Chaperone Inducer U133 in a Model of the Preclinical Stage of Parkinson’s Disease in Elderly Rats
inferred← citeshttps://doi.org/10.1007/s11515-014-1337-8openalex-snapshot
Mitochondrial dysfunction in Parkinson’s disease: a possible target for neuroprotection
inferred← citeshttps://doi.org/10.1007/s11756-024-01713-6openalex-snapshot
Comparative protein structural analyses of α-synuclein linked pathogenic variants reveal the role of N-terminally located critical region in Parkinson’s disease pathogenesis
inferred← citeshttps://doi.org/10.1007/s11910-019-0918-yopenalex-snapshot
CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD
inferred← citeshttps://doi.org/10.1007/s12017-016-8435-5openalex-snapshot
Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways
inferred← citeshttps://doi.org/10.1007/s12031-018-1057-7openalex-snapshot
The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s12035-014-8858-7openalex-snapshot
Potential of Cellular and Animal Models Based on a Prion-Like Propagation of α-Synuclein for Assessing Antiparkinson Agents
inferred← citeshttps://doi.org/10.1007/s12035-016-9717-5openalex-snapshot
Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice
inferred← citeshttps://doi.org/10.1007/s12035-017-0726-9openalex-snapshot
Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress
inferred← citeshttps://doi.org/10.1007/s12035-024-04204-6openalex-snapshot
A Mutual Nexus Between Epilepsy and α-Synuclein: A Puzzle Pathway
inferred← citeshttps://doi.org/10.1007/s12264-016-0092-zopenalex-snapshot
Exosomes in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s12311-015-0673-9openalex-snapshot
α-Synuclein Expression in the Mouse Cerebellum Is Restricted to VGluT1 Excitatory Terminals and Is Enriched in Unipolar Brush Cells
inferred← citeshttps://doi.org/10.1007/s12640-012-9366-zopenalex-snapshot
Potassium Depolarization and Raised Calcium Induces α-Synuclein Aggregates
inferred← citeshttps://doi.org/10.1007/s12640-017-9825-7openalex-snapshot
Dexamethasone Inhibits Copper-Induced Alpha-Synuclein Aggregation by a Metallothionein-Dependent Mechanism
inferred← citeshttps://doi.org/10.1007/s12668-024-01659-8openalex-snapshot
Unveiling the Cutting Edge: Recent Developments in α-Synuclein Nano-biosensor Technology for Precision Diagnosis of Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s13760-016-0679-1openalex-snapshot
α-Synuclein-carrying extracellular vesicles in Parkinson’s disease: deadly transmitters
inferred← citeshttps://doi.org/10.1007/s40120-018-0122-zopenalex-snapshot
Emerging Immunotherapies for Parkinson Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-816475-4.00020-3openalex-snapshot
Identification of biomarkers for diagnosing and monitoring therapy in the treatment of neurologic disorders
inferred← citeshttps://doi.org/10.1016/b978-0-12-818084-6.00002-7openalex-snapshot
Overview of Alzheimer's and Parkinson's diseases and the role of protein aggregation in these neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-822790-9.00005-xopenalex-snapshot
Excess activity of 3-hydroxykynurenine, quinolinic acid, and other toxic tryptophan metabolites in neurogenerative diseases and other protein misfolding diseases
inferred← citeshttps://doi.org/10.1016/b978-0-323-89774-7.00002-9openalex-snapshot
MicroRNAs in neurological diseases
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2020.11.001openalex-snapshot
Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight
inferred← citeshttps://doi.org/10.1016/j.arr.2015.01.003openalex-snapshot
DAMPs as mediators of sterile inflammation in aging-related pathologies
inferred← citeshttps://doi.org/10.1016/j.bbadis.2014.01.009openalex-snapshot
Identification of motives mediating alternative functions of the neomorphic moonlighting TPPP/p25
inferred← citeshttps://doi.org/10.1016/j.bbadis.2014.06.024openalex-snapshot
Preventing α-synuclein aggregation: The role of the small heat-shock molecular chaperone proteins
inferred← citeshttps://doi.org/10.1016/j.bbadis.2016.09.017openalex-snapshot
Challenging drug target for Parkinson's disease: Pathological complex of the chameleon TPPP/p25 and alpha-synuclein proteins
inferred← citeshttps://doi.org/10.1016/j.bbadis.2025.167862openalex-snapshot
Parkinson's disease and gut microbiota metabolites: The dual impact of vitamins and functional amyloids
inferred← citeshttps://doi.org/10.1016/j.bbapap.2015.08.009openalex-snapshot
Small-angle neutron scattering reveals the assembly of alpha-synuclein in lipid membranes
inferred← citeshttps://doi.org/10.1016/j.bbapap.2017.02.014openalex-snapshot
Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative
inferred← citeshttps://doi.org/10.1016/j.bbapap.2018.02.005openalex-snapshot
Capreomycin inhibits the initiation of amyloid fibrillation and suppresses amyloid induced cell toxicity
inferred← citeshttps://doi.org/10.1016/j.bbrc.2022.11.049openalex-snapshot
HtrA2 regulates α-Synuclein-mediated mitochondrial reactive oxygen species production in the mitochondria of microglia
inferred← citeshttps://doi.org/10.1016/j.bbrc.2025.152452openalex-snapshot
Perilla-derived chalcone inhibits α-synuclein fibrillization and prevents aggregate-induced disruption of intracellular α-synuclein conformation in neuronal cells
inferred← citeshttps://doi.org/10.1016/j.bcp.2023.115566openalex-snapshot
Want of Wnt in Parkinson’s disease: Could sFRP disrupt interplay between Nurr1 and Wnt signaling?
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.12.101openalex-snapshot
Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer’s disease, Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.bmcl.2018.02.031openalex-snapshot
Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregation
inferred← citeshttps://doi.org/10.1016/j.bpc.2021.106736openalex-snapshot
Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis
inferred← citeshttps://doi.org/10.1016/j.bpc.2022.106934openalex-snapshot
Ganglioside GM3 stimulates lipid-protein co-assembly in α-synuclein amyloid formation
inferred← citeshttps://doi.org/10.1016/j.bpj.2020.12.031openalex-snapshot
Internalization of α-synuclein oligomers into SH-SY5Y cells
inferred← citeshttps://doi.org/10.1016/j.brainres.2023.148410openalex-snapshot
Decreased levels of alpha synuclein in families with autism spectrum disorder and relationship between the disease severity
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2016.03.012openalex-snapshot
Physical activity and exercise attenuate neuroinflammation in neurological diseases
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2025.111516openalex-snapshot
Inhibition of DYRK1A can alleviate MPTP/MPP+-induced neuronal apoptosis and mitochondrial damage
inferred← citeshttps://doi.org/10.1016/j.cca.2019.04.078openalex-snapshot
Parkinson's and Lewy body dementia CSF biomarkers
inferred← citeshttps://doi.org/10.1016/j.celrep.2018.05.074openalex-snapshot
Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers
inferred← citeshttps://doi.org/10.1016/j.chembiol.2025.12.007openalex-snapshot
The interplay between autophagy and unconventional secretion in neurodegeneration
inferred← citeshttps://doi.org/10.1016/j.chemosphere.2025.144477openalex-snapshot
Lead as an environmental toxicant in models of synucleinopathies
inferred← citeshttps://doi.org/10.1016/j.ejmech.2017.10.002openalex-snapshot
A routinely used protein staining dye acts as an inhibitor of wild type and mutant alpha-synuclein aggregation and modulator of neurotoxicity
inferred← citeshttps://doi.org/10.1016/j.ejphar.2018.12.027openalex-snapshot
Aldehyde adducts inhibit 3,4-dihydroxyphenylacetaldehyde-induced α-synuclein aggregation and toxicity: Implication for Parkinson neuroprotective therapy
inferred← citeshttps://doi.org/10.1016/j.ejphar.2022.175204openalex-snapshot
Neuroprotective repositioning and anti-tau effect of carvedilol on rotenone induced neurotoxicity in rats: Insights from an insilico& in vivo anti-Parkinson's disease study
inferred← citeshttps://doi.org/10.1016/j.etp.2016.12.007openalex-snapshot
Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment
inferred← citeshttps://doi.org/10.1016/j.expneurol.2015.04.019openalex-snapshot
In vivo protein targets for increased quinoprotein adduct formation in aged substantia nigra
inferred← citeshttps://doi.org/10.1016/j.expneurol.2016.05.040openalex-snapshot
Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy
inferred← citeshttps://doi.org/10.1016/j.febslet.2013.07.053openalex-snapshot
Extracellular alpha‐synuclein induces calpain‐dependent overactivation of cyclin‐dependent kinase 5 in vitro
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2018.04.559openalex-snapshot
Early events in copper-ion catalyzed oxidation of α-synuclein
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.143883openalex-snapshot
Unraveling the unique amyloid-like aggregation behavior of the tumor suppressor p53 mutants in human cancers
inferred← citeshttps://doi.org/10.1016/j.ijms.2025.117455openalex-snapshot
Mass spectrometry structural analysis of intrinsically disordered phosphoproteins
inferred← citeshttps://doi.org/10.1016/j.jbc.2022.102688openalex-snapshot
A penetratin-derived peptide reduces the membrane permeabilization and cell toxicity of α-synuclein oligomers
inferred← citeshttps://doi.org/10.1016/j.jep.2023.116897openalex-snapshot
Ashwagandha- Withania somnifera (L.) Dunal as a multipotent neuroprotective remedy for genetically induced motor dysfunction and cellular toxicity in human neurodegenerative disease models of Drosophila
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2014.06.004openalex-snapshot
Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2017.12.003openalex-snapshot
Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood
inferred← citeshttps://doi.org/10.1016/j.mad.2015.04.001openalex-snapshot
PARP-1 involvement in neurodegeneration: A focus on Alzheimer’s and Parkinson’s diseases
inferred← citeshttps://doi.org/10.1016/j.mcn.2015.02.015openalex-snapshot
The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to α-synuclein inclusions
inferred← citeshttps://doi.org/10.1016/j.mcn.2016.10.003openalex-snapshot
Alpha-synuclein aggregates are excluded from calbindin-D28k-positive neurons in dementia with Lewy bodies and a unilateral rotenone mouse model
inferred← citeshttps://doi.org/10.1016/j.molimm.2022.12.006openalex-snapshot
Aggregated alpha-synuclein transcriptionally activates pro-inflammatory canonical and non-canonical NF-κB signaling pathways in peripheral monocytic cells
inferred← citeshttps://doi.org/10.1016/j.molliq.2020.113198openalex-snapshot
Silybin as a potent inhibitor of a-synuclein aggregation and associated cytotoxicity against neuroblastoma cells induced by zinc oxide nanoparticles
inferred← citeshttps://doi.org/10.1016/j.nbd.2014.05.009openalex-snapshot
Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice
inferred← citeshttps://doi.org/10.1016/j.nbd.2014.06.018openalex-snapshot
α-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent manner
inferred← citeshttps://doi.org/10.1016/j.nbd.2014.10.011openalex-snapshot
Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous α-synuclein fibrils
inferred← citeshttps://doi.org/10.1016/j.nbd.2015.05.004openalex-snapshot
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative
inferred← citeshttps://doi.org/10.1016/j.nbd.2022.105654openalex-snapshot
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.nbd.2022.105796openalex-snapshot
The Rab11-regulated endocytic pathway and BDNF/TrkB signaling: Roles in plasticity changes and neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.nbt.2014.05.001openalex-snapshot
Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.neuint.2012.11.004openalex-snapshot
Raised calcium and oxidative stress cooperatively promote alpha-synuclein aggregate formation
inferred← citeshttps://doi.org/10.1016/j.neuint.2018.08.005openalex-snapshot
Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.neuint.2020.104758openalex-snapshot
Astrocyte glutamate transporters are increased in an early sporadic model of synucleinopathy
inferred← citeshttps://doi.org/10.1016/j.neulet.2017.08.006openalex-snapshot
The PMR1 pump in alpha-synuclein toxicity and neurodegeneration
inferred← citeshttps://doi.org/10.1016/j.neuro.2014.08.006openalex-snapshot
Correlation between the biochemical pathways altered by mutated parkinson-related genes and chronic exposure to manganese
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2024.12.057openalex-snapshot
The investigation of peripheral inflammatory and oxidative stress biomarkers in dementia with Lewy Bodies, compared with Alzheimer’s Disease, and mild cognitive impairment
inferred← citeshttps://doi.org/10.1016/j.nicl.2018.07.028openalex-snapshot
Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2022.04.001openalex-snapshot
Tracer development for PET imaging of proteinopathies
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2013.01.013openalex-snapshot
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
inferred← citeshttps://doi.org/10.1016/j.semcdb.2017.08.046openalex-snapshot
Amyloid and membrane complexity: The toxic interplay revealed by AFM
inferred← citeshttps://doi.org/10.1016/j.stemcr.2016.08.012openalex-snapshot
Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation
inferred← citeshttps://doi.org/10.1016/j.tcb.2015.08.007openalex-snapshot
Cell Biology of Prions and Prionoids: A Status Report
inferred← citeshttps://doi.org/10.1016/j.toxlet.2016.04.014openalex-snapshot
In vitro neurotoxic hazard characterisation of dinitrophenolic herbicides
inferred← citeshttps://doi.org/10.1016/j.ydbio.2015.10.028openalex-snapshot
Expression of polyQ aggregates in Malpighian tubules leads to degeneration in Drosophila melanogaster
inferred← citeshttps://doi.org/10.1016/s1474-4422(15)00186-6openalex-snapshot
Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson's disease
inferred← citeshttps://doi.org/10.1021/acs.analchem.7b02090openalex-snapshot
Monitoring Early-Stage Protein Aggregation by an Aggregation-Induced Emission Fluorogen
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b00571openalex-snapshot
Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein Fibrils
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01376openalex-snapshot
5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors
inferred← citeshttps://doi.org/10.1021/acsabm.3c00364openalex-snapshot
Applications and Considerations for Microfluidic Systems To Model the Blood–Brain Barrier
inferred← citeshttps://doi.org/10.1021/bi301475qopenalex-snapshot
Coordination of Copper to the Membrane-Bound Form of α-Synuclein
inferred← citeshttps://doi.org/10.1038/cdd.2014.111openalex-snapshot
GRP78 clustering at the cell surface of neurons transduces the action of exogenous alpha-synuclein
inferred← citeshttps://doi.org/10.1038/cdd.2015.79openalex-snapshot
Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death
inferred← citeshttps://doi.org/10.1038/cddis.2014.307openalex-snapshot
DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson’s disease
inferred← citeshttps://doi.org/10.1038/cddiscovery.2017.53openalex-snapshot
Amyloid single-cell cytotoxicity assays by nanomotion detection
inferred← citeshttps://doi.org/10.1038/nn.4648openalex-snapshot
α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B
inferred← citeshttps://doi.org/10.1038/nrneurol.2013.275openalex-snapshot
Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases
inferred← citeshttps://doi.org/10.1038/s41419-022-05030-1openalex-snapshot
p21-activated kinase 4 controls the aggregation of α-synuclein by reducing the monomeric and aggregated forms of α-synuclein: involvement of the E3 ubiquitin ligase NEDD4-1
inferred← citeshttps://doi.org/10.1038/s41467-021-26066-5openalex-snapshot
Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
inferred← citeshttps://doi.org/10.1038/s41556-026-01870-7openalex-snapshot
Ectosomes step forward in α-synuclein spread
inferred← citeshttps://doi.org/10.1038/s41583-020-00416-6openalex-snapshot
Reverse engineering Lewy bodies: how far have we come and how far can we go?
inferred← citeshttps://doi.org/10.1038/s41598-017-07383-6openalex-snapshot
Novel animal model defines genetic contributions for neuron-to-neuron transfer of α-synuclein
inferred← citeshttps://doi.org/10.1038/s41598-017-14175-5openalex-snapshot
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson’s disease
inferred← citeshttps://doi.org/10.1038/s41598-018-26905-4openalex-snapshot
Sir-2.1 mediated attenuation of α-synuclein expression by Alaskan bog blueberry polyphenols in a transgenic model of Caenorhabditis elegans
inferred← citeshttps://doi.org/10.1038/s41598-018-35277-8openalex-snapshot
The codon sequences predict protein lifetimes and other parameters of the protein life cycle in the mouse brain
inferred← citeshttps://doi.org/10.1038/s42003-020-0883-7openalex-snapshot
Freezing and piercing of in vitro asymmetric plasma membrane by α-synuclein
inferred← citeshttps://doi.org/10.1038/srep05648openalex-snapshot
Effects of several quinones on insulin aggregation
inferred← citeshttps://doi.org/10.1038/srep09862openalex-snapshot
Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein
inferred← citeshttps://doi.org/10.1039/9781782622383-00221openalex-snapshot
Mutual Neurotoxic Mechanisms Controlling Manganism and Parkisonism
inferred← citeshttps://doi.org/10.1039/9781849737357-00175openalex-snapshot
Synuclein and Parkinson’s Disease: An Update
inferred← citeshttps://doi.org/10.1039/c6ay02011aopenalex-snapshot
A novel method to predict protein aggregations using two-dimensional native protein microfluidic chip electrophoresis
inferred← citeshttps://doi.org/10.1039/c7cs00372bopenalex-snapshot
Implications of peptide assemblies in amyloid diseases
inferred← citeshttps://doi.org/10.1039/d0tb02745fopenalex-snapshot
Recent advances in enzymeless-based electrochemical sensors to diagnose neurodegenerative diseases
inferred← citeshttps://doi.org/10.1039/d4an00453aopenalex-snapshot
A binding-triggered hybridization chain reaction cascade multi-site activated CRISPR/Cas12a signal amplification strategy for sensitive detection of α-synuclein
inferred← citeshttps://doi.org/10.1042/bj20150159openalex-snapshot
Distinct higher-order α-synuclein oligomers induce intracellular aggregation
inferred← citeshttps://doi.org/10.1053/j.semnuclmed.2017.06.003openalex-snapshot
Small-molecule PET Tracers for Imaging Proteinopathies
inferred← citeshttps://doi.org/10.1055/a-2052-8462openalex-snapshot
Consequence of Dementia and Cognitive Impairment by Primary Nucleation Pathway
inferred← citeshttps://doi.org/10.1063/1.4942115openalex-snapshot
A coarse grained protein model with internal degrees of freedom. Application to α -synuclein aggregation
inferred← citeshttps://doi.org/10.1063/5.0151300openalex-snapshot
Highly sensitive biosensor based on IGZO thin-film transistors for detection of Parkinson's disease
inferred← citeshttps://doi.org/10.1073/pnas.2501987122openalex-snapshot
Amyloid-β modulates the phase separation and aggregation of α-synuclein
inferred← citeshttps://doi.org/10.1074/jbc.ra118.002414openalex-snapshot
Functional proteasome complex is required for turnover of islet amyloid polypeptide in pancreatic β-cells
inferred← citeshttps://doi.org/10.1074/jbc.ra118.004267openalex-snapshot
Glycosaminoglycans have variable effects on α-synuclein aggregation and differentially affect the activities of the resulting amyloid fibrils
inferred← citeshttps://doi.org/10.1080/10937404.2014.976893openalex-snapshot
A Curated Review of Recent Literature of Biomarkers Used for Assessing Air Pollution Exposures and Effects in Humans
inferred← citeshttps://doi.org/10.1080/14737159.2017.1341312openalex-snapshot
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease
inferred← citeshttps://doi.org/10.1080/14789450.2017.1304216openalex-snapshot
Role of the microtubule-associated TPPP/p25 in Parkinson’s and related diseases and its therapeutic potential
inferred← citeshttps://doi.org/10.1080/19336950.2015.1063285openalex-snapshot
Raft-partitioning of calcium channels regulates their function
inferred← citeshttps://doi.org/10.1080/19768354.2021.1883735openalex-snapshot
Analysis of α-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson’s disease
inferred← citeshttps://doi.org/10.1089/ars.2022.0076openalex-snapshot
Uncovering the Molecular Link Between Lead Toxicity and Parkinson's Disease
inferred← citeshttps://doi.org/10.1089/omi.2017.0056openalex-snapshot
A Systems Model of Parkinson's Disease Using Biochemical Systems Theory
inferred← citeshttps://doi.org/10.1093/brain/awx056openalex-snapshot
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
inferred← citeshttps://doi.org/10.1093/cercor/bhab244openalex-snapshot
α-Synuclein Selectively Impairs Motor Sequence Learning and Value Sensitivity: Reversal by the Adenosine A2A Receptor Antagonists
inferred← citeshttps://doi.org/10.1093/cercor/bhv268openalex-snapshot
Adenosine A2AReceptors Modulate α-Synuclein Aggregation and Toxicity
inferred← citeshttps://doi.org/10.1093/hmg/ddu391openalex-snapshot
The small GTPase Rab11 co-localizes with -synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity
inferred← citeshttps://doi.org/10.1093/hmg/ddu521openalex-snapshot
Rab11 modulates α-synuclein-mediated defects in synaptic transmission and behaviour
inferred← citeshttps://doi.org/10.1093/hmg/ddu576openalex-snapshot
Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS
inferred← citeshttps://doi.org/10.1093/med/9780198713005.003.0043openalex-snapshot
Dementia with Lewy bodies
inferred← citeshttps://doi.org/10.1096/fj.15-275131openalex-snapshot
Chaperome screening leads to identification of Grp94/Gp96 and FKBP4/52 as modulators of the α‐synuclein‐elicited immune response
inferred← citeshttps://doi.org/10.1097/nen.0000000000000014openalex-snapshot
Pedunculopontine Cholinergic Cell Loss in Hallucinating Parkinson Disease Patients but Not in Dementia With Lewy Bodies Patients
inferred← citeshttps://doi.org/10.1101/2024.10.10.617554openalex-snapshot
Lead as a toxic environmental toxicant in models of synucleinopathies
inferred← citeshttps://doi.org/10.1111/bpa.12370openalex-snapshot
Alpha‐Synuclein as a Biomarker for Parkinson's Disease
inferred← citeshttps://doi.org/10.1111/bph.13066openalex-snapshot
Beyond traditional pharmacology: new tools and approaches
inferred← citeshttps://doi.org/10.1111/cns.70299openalex-snapshot
Development of In Vitro Parkinson's Disease Model Mediated by MPP + and α‐Synuclein Using Wharton's Jelly Mesenchymal Stem Cells
inferred← citeshttps://doi.org/10.1111/jnc.12271openalex-snapshot
Harnessing the power of yeast to unravel the molecular basis of neurodegeneration
inferred← citeshttps://doi.org/10.1111/jnc.13971openalex-snapshot
Calcipotriol inhibits α‐synuclein aggregation in SH ‐ SY 5Y neuroblastoma cells by a Calbindin‐D28k‐dependent mechanism
inferred← citeshttps://doi.org/10.1111/jnc.14471openalex-snapshot
Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration
inferred← citeshttps://doi.org/10.1111/jnc.14704openalex-snapshot
How is alpha‐synuclein cleared from the cell?
inferred← citeshttps://doi.org/10.1111/jnc.15154openalex-snapshot
The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease
inferred← citeshttps://doi.org/10.1111/jnc.15992openalex-snapshot
PrP meets alpha‐synuclein: Molecular mechanisms and implications for disease
inferred← citeshttps://doi.org/10.1111/nan.12644openalex-snapshot
Peripheral inflammation exacerbates α‐synuclein toxicity and neuropathology in Parkinson's models
inferred← citeshttps://doi.org/10.1111/ncn3.57openalex-snapshot
Pathogenesis of multiple system atrophy
inferred← citeshttps://doi.org/10.1111/nyas.12577openalex-snapshot
Therapeutic strategies in Parkinson's disease: what we have learned from animal models
inferred← citeshttps://doi.org/10.1126/scisignal.2005965openalex-snapshot
Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders
inferred← citeshttps://doi.org/10.1152/physrev.00039.2017openalex-snapshot
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
inferred← citeshttps://doi.org/10.1155/2014/543673openalex-snapshot
Complex Network-Driven View of Genomic Mechanisms Underlying Parkinson’s Disease: Analyses in Dorsal Motor Vagal Nucleus, Locus Coeruleus, and Substantia Nigra
inferred← citeshttps://doi.org/10.1155/2018/4503871openalex-snapshot
Significant Changes in Plasma Alpha-Synuclein and Beta-Synuclein Levels in Male Children with Autism Spectrum Disorder
inferred← citeshttps://doi.org/10.11606/d.5.2013.tde-01082013-135108openalex-snapshot
Análise de redes de interação transcricional na substância nigra, locus cerúleo e núcleo dorsal do nervo vago na Doença de Parkinson
inferred← citeshttps://doi.org/10.1186/s12868-015-0192-0openalex-snapshot
Exogenous α-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes
inferred← citeshttps://doi.org/10.1186/s12964-025-02461-zopenalex-snapshot
Bridging the gap in Parkinson’s disease research: from general pathophysiology to advanced 3d cell culture models
inferred← citeshttps://doi.org/10.1186/s12967-026-08102-4openalex-snapshot
Peripheral immunochemical considerations in Parkinson disease: sources, targets and crosstalk mechanisms
inferred← citeshttps://doi.org/10.1186/s13024-019-0335-3openalex-snapshot
Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
inferred← citeshttps://doi.org/10.1186/s13041-017-0340-9openalex-snapshot
Oxidative stress and cellular pathologies in Parkinson’s disease
inferred← citeshttps://doi.org/10.1186/s40035-015-0026-0openalex-snapshot
Mini review: linkage between α-Synuclein protein and cognition
inferred← citeshttps://doi.org/10.1186/s40035-015-0039-8openalex-snapshot
Development of stem cell-based therapy for Parkinson’s disease
inferred← citeshttps://doi.org/10.1186/s40035-017-0099-zopenalex-snapshot
Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
inferred← citeshttps://doi.org/10.1186/s40035-023-00375-9openalex-snapshot
Research progress on the role of extracellular vesicles in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1186/s40478-016-0408-2openalex-snapshot
Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson’s disease
inferred← citeshttps://doi.org/10.1371/journal.pgen.1004741openalex-snapshot
Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation
inferred← citeshttps://doi.org/10.1371/journal.pone.0079160openalex-snapshot
Preconditioning of Microglia by α-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation
inferred← citeshttps://doi.org/10.1371/journal.pone.0083752openalex-snapshot
Structural and Dynamical Insights into the Membrane-Bound α-Synuclein
inferred← citeshttps://doi.org/10.1371/journal.pone.0091074openalex-snapshot
Roles of Autophagy in MPP+-Induced Neurotoxicity In Vivo: The Involvement of Mitochondria and α-Synuclein Aggregation
inferred← citeshttps://doi.org/10.1371/journal.pone.0115029openalex-snapshot
Differential Co-Expression between α-Synuclein and IFN-γ Signaling Genes across Development and in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1371/journal.pone.0162717openalex-snapshot
Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant
inferred← citeshttps://doi.org/10.14712/23362936.2018.8openalex-snapshot
Olfaction and Colour Vision: What Can They Tell Us about Parkinson’s Disease?
inferred← citeshttps://doi.org/10.15252/embj.201592770openalex-snapshot
α‐Synuclein oligomers pump it up!
showing the first 200 of 280 · page through all 280
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.